Moreover, there was no significant difference in the median titers of anti-α1AR (p = 0.77) and anti-M4R (p = 0.47) autoantibodies when comparing healthy controls without SBIs to subjects with SBIs who did not report cognitive impairment (Figure 3 and Table 3). This evidence concerns the gene CHRM4 and Cognitive impairment.